Reine Allan

CIK 0001714023

Chief Financial OfficerDirector

Filings

Latest Feb 27, 2026

Issuers covered

Showing

12 of 12

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+77.7%	+77.7%	+77.7%	+77.7%
90 days	1	100%	+178.1%	+178.1%	+178.1%	+178.1%
180 days	1	100%	+227.9%	+227.9%	+227.9%	+227.9%
365 days	1	100%	+153.2%	+153.2%	+153.2%	+153.2%

Companies where Reine Allan has filed

Ticker	Issuer	Filings	Last filed
PRME	Prime Medicine, Inc.	9	Feb 27, 2026
FHTX	Foghorn Therapeutics Inc.	3	Jan 17, 2024

12 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 27, 2026	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
Aug 5, 2025	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
May 22, 2025	PRMEPrime Medicine, Inc.	PPurchase	125,000	$1.1772	$147,150
May 19, 2025	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
May 12, 2025	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
Mar 3, 2025	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
Dec 9, 2024	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
May 21, 2024	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
Jan 19, 2024	PRMEPrime Medicine, Inc.	Holdings only	-	-	-
Jan 17, 2024	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-
Jan 30, 2023	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-
Jan 28, 2022	FHTXFoghorn Therapeutics Inc.	Holdings only	-	-	-

Showing 1-12 of 12

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.